Corgentech (CGTK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Corgentech (CGTK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tuck	11/5/2004 12:20:06 PM
	Read Replies (1) of 39

>>Suppression of Anastomotic Intimal Hyperplasia in Rabbit Hypercholesterolemic Model Using Chimeric Decoy Oligodeoxynucleotides (ODN) Against NF?B and E2F<< This is the title of an abstract by an apparently unrelated (to CGTK) Japanese team, being presented at the upcoming AHA meeting in New Orleans. The text is available for free sign up. It seems to support CGTK's approach, though I don't off hand recall that the E2F Decoy inhibits NFkB. It's the only vaguely related abstract I could find, so I gather CGTK isn't doing anything at this year's AHA. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next